KAM
VIRX

Kazazian Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Kazazian Asset Management’s Portfolio VIRX Stock Details VIRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-35,000
Closed -$70K – 90
2018
Q3 		$70K Buy
+35,000
New +$70K 0.07% 89